The HAL team has years of immunology and cancer research experience in academic, translational, and clinical settings. Our robust and reproducible analyses are designed to expedite the discovery and IND-enabling phases to accelerate your research and development. We employ state-of-the-art techniques and devices to assess identity, purity, safety, and potency of your preclinical biological product. We maintain expertise in flow cytometry, immuonfluorescence, live cell imaging, cytotoxicity assays, and clinical laboratory testing.
Our PhD scientists have expertise in isolating and characterizing primary human αβT cells, γδT cells, NK cells, Dendritic cells, and Tumor Cells. Please see below for a detailed list of our RUO analytical services designed by our scientists and performed by highly competent research staff: